Skip to main content

7 Result(s)

within G E Tjønnfjord Remove this filter

and

  1. No Access

    Article

    HLA-DPB1 mismatch reduce relapse and improve survival in T-cell replete unrelated donor allogeneic stem cell transplantation

    B. Grønvold, M. M. Ali, M. Remberger, J. Mattsson… in Bone Marrow Transplantation (2020)

  2. Article

    Open Access

    The CD34+ Cell Dose Matters in Hematopoietic Stem Cell Transplantation with Peripheral Blood Stem Cells from Sibling Donors

    The effect of CD34+ cell dose in allogeneic hematopoietic stem cell transplantation (HSCT) on overall survival (OS) and incidence of acute and chronic graft-versus-host disease (GvHD) has not been established and...

    M. Remberger, B. Grønvold, M. Ali, J. Mattsson… in Clinical Hematology International (2020)

    Download PDF (621 KB)

  3. Article

    Open Access

    Body weight, body composition and survival after 1 year: follow-up of a nutritional intervention trial in allo-HSCT recipients

    The role of body weight change in survival among recipients of hematopoietic stem-cell transplantation is controversial. We assessed the effect of optimizing energy and protein intake on 1-year survival, body ...

    K. J. Skaarud, M. B. Veierød, S. Lergenmuller, A. Bye… in Bone Marrow Transplantation (2019)

    Download PDF (636 KB) View Article

  4. No Access

    Article

    Autologous bone marrow Th cells can support multiple myeloma cell proliferation in vitro and in xenografted mice

    Multiple myeloma (MM) is a plasma cell malignancy where MM cell growth is supported by the bone marrow (BM) microenvironment with poorly defined cellular and molecular mechanisms. MM cells express CD40, a rece...

    D Wang, Y Fløisand, C V Myklebust, S Bürgler, A Parente-Ribes, P O Hofgaard… in Leukemia (2017)

  5. No Access

    Article

    Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation

    Reduced-intensity conditioning (RIC) allo-SCT is a potentially curative treatment approach for patients with relapsed Hodgkin’s or non-Hodgkin’s lymphoma. In the present study, 37 patients underwent RIC allo-S...

    Y Fløisand, L Brinch, T Gedde-Dahl, G E Tjønnfjord… in Bone Marrow Transplantation (2012)

  6. No Access

    Article

    Treatment outcome in adults with acute lymphoblastic leukemia: 50% long-term disease-free survival

    G E Tjønnfjord, T Gedde-Dahl III, D Heldal, L Brinch in Leukemia (2007)

  7. No Access

    Article

    Skin biopsies for early diagnosis and prognosis of graft-versus-host disease in recipients of allogeneic stem cells from blood or bone marrow

    A total of 61 patients with haematological malignancies were randomised either to allogeneic transplantation with blood stem cells (BSC) or bone marrow (BM), of whom 37 patients gave their consent to participa...

    D Heldal, L Brinch, S A Evensen, G E Tjønnfjord, G Aamodt… in Bone Marrow Transplantation (2004)